Breaking News: Embargoed Feed - hidden

Filters close
13-Sep-2024 9:45 AM EDT
ESMO: Combination Therapy Reduced Agitated Delirium in Patients with Advanced Cancers
University of Texas MD Anderson Cancer Center

Treatment with a combination of haloperidol and lorazepam reduced symptoms of agitated delirium, a common end-of-life condition for patients with advanced cancers, compared with haloperidol alone, according to a new study led by researchers at The University of Texas MD Anderson Cancer Center.

Not for public release

This news release is embargoed until 16-Sep-2024 11:00 AM EDT Released to reporters: 13-Sep-2024 3:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 16-Sep-2024 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 18-Sep-2024 11:00 AM EDT Released to reporters: 13-Sep-2024 1:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 18-Sep-2024 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 15-Sep-2024 7:05 PM EDT Released to reporters: 13-Sep-2024 12:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 15-Sep-2024 7:05 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 13-Sep-2024 11:00 AM EDT Released to reporters: 11-Sep-2024 11:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 13-Sep-2024 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

   
access_time Embargo lifts in 2 days
This news release is embargoed until 18-Sep-2024 5:00 PM EDT Released to reporters: 13-Sep-2024 10:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 18-Sep-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Folded or Cut, This Lithium-Sulfur Battery Keeps Going
11-Sep-2024 8:00 AM EDT
Folded or Cut, This Lithium-Sulfur Battery Keeps Going
American Chemical Society (ACS)

Researchers reporting in ACS Energy Letters have designed a lithium-sulfur (Li-S) battery that features an improved iron sulfide cathode. One prototype remains highly stable over 300 charge-discharge cycles, and another provides power even after being folded or cut.

access_time Embargo lifts in 2 days
This news release is embargoed until 16-Sep-2024 11:00 AM EDT Released to reporters: 13-Sep-2024 7:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 16-Sep-2024 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 18-Sep-2024 12:00 PM EDT Released to reporters: 13-Sep-2024 7:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 18-Sep-2024 12:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

       
access_time Left Before Reporter's Deadline
Reporter's Deadline: 16-Sep-2024 11:59 PM EDT
12-Sep-2024 4:57 PM EDT
US cut-flower cultivation, current - Maryn McKenna, Scientific American

US cut-flower cultivation, current production or history: For a piece on the rise of

access_time Embargo lifts in 2 days
This news release is embargoed until 18-Sep-2024 12:00 PM EDT Released to reporters: 12-Sep-2024 4:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 18-Sep-2024 12:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 18-Sep-2024 4:00 PM EDT Released to reporters: 12-Sep-2024 3:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 18-Sep-2024 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 18-Sep-2024 4:00 PM EDT Released to reporters: 12-Sep-2024 3:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 18-Sep-2024 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 17-Sep-2024 7:05 PM EDT Released to reporters: 12-Sep-2024 1:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 17-Sep-2024 7:05 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 17-Sep-2024 11:00 AM EDT Released to reporters: 12-Sep-2024 12:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 17-Sep-2024 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: UTHealth Houston School of Public Health Unveils a New Home in Austin Designed for Collaboration, Education, Research
10-Sep-2024 11:05 AM EDT
UTHealth Houston School of Public Health Unveils a New Home in Austin Designed for Collaboration, Education, Research
University of Texas Health Science Center at Houston

A modern education space that is inclusive, safe, flexible, and environmentally conscious will be unveiled today as the new home of the UTHealth Houston School of Public Health in Austin.

access_time Embargo lifts in 2 days
This news release is embargoed until 17-Sep-2024 11:00 AM EDT Released to reporters: 12-Sep-2024 10:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 17-Sep-2024 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Left Before Reporter's Deadline
Reporter's Deadline: 15-Sep-2024 7:00 PM EDT
12-Sep-2024 9:50 AM EDT
I would like to interview - Jack A Wax, Next Avenue; Third Age, etc.

I would like to interview an expert who can explain the effects of one partner

access_time Embargo lifts in 2 days
This news release is embargoed until 17-Sep-2024 9:00 AM EDT Released to reporters: 12-Sep-2024 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 17-Sep-2024 9:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: New national survey shows hesitancy about vaccines this fall
11-Sep-2024 11:05 AM EDT
New national survey shows hesitancy about vaccines this fall
Ohio State University Wexner Medical Center

With flu season just around the corner and COVID-19 cases on the rise, a new nationwide survey from The Ohio State University Wexner Medical Center reveals hesitancy around vaccines this fall. The new data comes just as this year’s flu shot rolls out and following the FDA’s approval of an updated round of COVID-19 vaccines.



close
7.64618